A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors (CYCAD-1)
NCT 06188520 Brief Summary This study is designed to evaluate AZD8421 alone…
Read more arrow_forward